Skip to content

Requiem for UK R&D

Science minister David Willetts recently claimed that universities were responsible for picking up the slack in R&D following Pfizer’s run for the hills – in this writer’s opinion the first of many rats* to flee this sinking ship.

We need only cast our minds back a month or so to remember the government’s announcement that universities would be facing a 9.5% cut in funding in 2011-12, with a 4% cut in research funding. This makes the whole situation feel a lot like 1 step backwards and 2 steps back.

So what is the government trying to achieve?

Well, it’s a mystery to me. They claim their commitment to improving pharmaceutical research in the UK, yet the above points make this seem impossible. Add this to the push for value-based pricing and this really seems like the death of quality research in the UK.

Am I the only one with such fears?

*used only for metaphorical purposes – not pejorative!

We now have a newsletter!

Sign up to receive updates about the blog and the wider health economics world.

0 0 votes
Article Rating
Notify of

Oldest Most Voted
Inline Feedbacks
View all comments
Chris Sampson
Chris Sampson
13 years ago

Giving with one hand and taking away with the other?
Government injects £775m into NHS translational research

13 years ago

Just thinking back to this…..
If Pharma’s spent a bit less on their marketing then this wouldn’t be necessary!

Also you will find this recently published article a fascinating read….again about how pharma’s are not doing us justice….

Join the conversation, add a commentx